Academic Journals Database
Disseminating quality controlled scientific knowledge

The Clinic Analysis of Diclofenac Suppository for Oocyte Retrieval Analgesia in IVF-ET Cycles

Author(s): Yubin Li | Qingyun Mai | Tao Li | Yiping Zhong | Canquan Zhou

Journal: International Journal of Clinical Medicine
ISSN 2158-284X

Volume: 04;
Issue: 08;
Start page: 350;
Date: 2013;
Original page

Keywords: Diclofenac Suppository | IVF-ET | Oocyte Retrieval | Analgesia

Objective: To study the effect of diclofenac suppository in oocyte retrieval of IVF-ET. Study Design: 1176 patients with informed consents were enrolled into this prospective randomized controlled study. The setting was an IVF-ET program at the First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China. According to the analgesic drug use, the patients were randomly divided into pethidine group (573 cases) and diclofenac suppository group (603 cases). The data of vital signs, common adverse reactions, severe adverse events and pain degree in oocyte retrieval were collected. The IVF-ET outcomes were also compared. Results: The post-operation pressure and pulse were lower in pethidine group than in diclofenac suppository group (both P0.05). Common adverse reactions in diclofenac suppository group were relative less (all P0.05). There were 3 cases serious abdominal bleeding with shock in the diclofenac suppository group. Conclusion: Using diclofenac suppository in oocyte retrieval analgesic had a good effect. And there was no adverse effect in the IVF-ET outcome. But we should pay close attention to the probability of serious abdominal bleeding.
Affiliate Program      Why do you need a reservation system?